Innovative Technologies & Techniques | Silent Leaflet Thrombosis (SLT) After TAVR: What Are the Causes and How to Treat It
In Episode 18 of the Texas Heart Institute (THI) Education Series, Innovative Technologies & Techniques, Dr. Zvonimir Krajcer discusses silent leaflet thrombosis (SLT) after TAVR. He covers the causes and how to treat it.
The Texas Heart Institute (THI) is recognized internationally for research programs in cardiology, cardiovascular surgery, regenerative medicine, and endovascular interventions. Our physicians, surgeons, and scientists conduct research ranging from gene therapy, regenerative medicine, and minimally invasive surgical procedures to ventricular assist devices and artificial hearts. THI provides a collection of online activities to further the education of physicians and other medical professionals beyond the walls of the institution on the most relevant topics in cardiovascular health and patient care. The Institute’s educational activities include postdoctoral and allied training programs, seminars, symposia, grand rounds, scientific publications, and public education outreach. Other online resources for professionals and the community include the THI Journal, THI Grand Rounds Archives, and the Heart Information Center.
